San Diego, CA, United States of America

Rebecca Saenz

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca Saenz. Retrieved from https://idiyas.com/inventor/rebecca-saenz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Rebecca Saenz

Introduction

Rebecca Saenz is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of immunology through her innovative research and inventions. With a total of 2 patents, her work focuses on enhancing immune responses to antigens.

Latest Patents

Rebecca Saenz's latest patents include the development of HMGB1-derived peptides that enhance immune response to antigens. The first patent provides an immunostimulatory peptide containing the amino acid sequence SAFFLFCSE and outlines its various uses. Additionally, the invention includes another immunostimulatory peptide with the amino acid sequence DPNAPKRPPSAFFLXXXX or derivatives thereof. The patent details specific embodiments where variations in the amino acid sequences can lead to enhanced immunological effects.

Career Highlights

Rebecca Saenz is affiliated with the University of California, where she conducts her research and develops her inventions. Her work has garnered attention for its potential applications in immunotherapy and vaccine development.

Collaborations

Rebecca collaborates with her coworker, Davorka Messmer, who is also a prominent figure in the field. Together, they contribute to advancing research in immunology and related areas.

Conclusion

Rebecca Saenz's innovative work in developing immunostimulatory peptides showcases her dedication to enhancing immune responses. Her contributions are significant in the ongoing efforts to improve immunological therapies and treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…